Bactolac Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-12-2024
- Paid Up Capital ₹ 2.22 M
as on 17-12-2024
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.91 Cr
as on 17-12-2024
- Revenue 324.58%
(FY 2022)
- Profit 28.58%
(FY 2022)
- Ebitda -225.99%
(FY 2022)
- Net Worth 32.89%
(FY 2022)
- Total Assets 172.61%
(FY 2022)
About Bactolac Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.22 M.
The company currently has active open charges totaling ₹1.91 Cr.
Veera Damarla and Syamala Kanuri serve as directors at the Company.
- CIN/LLPIN
U24230TG1993PTC015641
- Company No.
015641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bactolac Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Damarla  | Director | 02-Dec-2024 | Current |
| Syamala Kanuri | Director | 29-Mar-2024 | Current |
Financial Performance of Bactolac Formulations.
Bactolac Formulations Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 324.58% increase. The company also saw a substantial improvement in profitability, with a 28.58% increase in profit. The company's net worth Soared by an impressive increase of 32.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bactolac Formulations?
In 2020, Bactolac Formulations had a promoter holding of 0.01% and a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 08 Nov 2004 | ₹5.75 M | Open |
Bank Of Baroda Creation Date: 05 Jul 2004 | ₹0.50 M | Open |
Bank Of Baroda Creation Date: 05 Dec 2002 | ₹2.50 M | Open |
How Many Employees Work at Bactolac Formulations?
Bactolac Formulations has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bactolac Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bactolac Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
